Who we are
Harle Group Inc. and HarlePhil Venture Inc (a wholly owned subsidiary of Harle Group Inc.) have forged connections between cutting edge life science technologies and their target market in Asia. Our focus is on technologies that promote the personalized medicine approach in the diagnosis and treatment of serious diseases.
What we believe
Harle Group Inc. believes that the future of medicine lies in the understanding of the 3 billion units of DNA that make up a human genome. The Human Genome Project had been completed after more than 10 years of intensive research. Life science companies have began to show success in the fields of cancer, cardiac health, pain management, pre-natal condition, organ transplants and many more.
Harle Group intends to extend each success story to target markets in Asia.